• About Us
    • Company Overview
    • Our History
    • Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Our Advisors
  • Therapeutic Areas
    • COVID-19 and CVD
    • Acute Myocarditis
    • Heart Failure
  • Research
    • R&D Partners
    • Our Science
    • Resources
  • Pipeline
  • CardiolRX™
  • Investors
    • Events & Presentations
    • Press Releases
    • Analyst Coverage
    • Stock Information
    • Filings & Financials
    • Corporate Governance
    • Contact Us
  • Events & Presentations
  • Press Releases
  • Analyst Coverage
  • Stock Information
  • Filings & Financials
  • Corporate Governance
  • Investor Relations Contact
Investors

Press Releases

Press Release

Cardiol Therapeutics Receives Health Canada Approval for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis

October 25, 2021

Press Release

Cardiol Therapeutics Expands LANCER, a Phase II/III Trial of CardiolRx™, into Brazil, Mexico, and Canada

October 18, 2021

Press Release

Cardiol Therapeutics to Participate in the 2021 Cantor Virtual Global Healthcare Conference

September 16, 2021

Press Release

Cardiol Therapeutics Announces Acceleration of Expiry Date of Warrants issued on June 4, 2020

September 10, 2021

Press Release

Cardiol Therapeutics Appoints Michael J. Willner to its Board of Directors

September 07, 2021

Press Release

Cardiol Therapeutics Receives FDA Clearance of Investigational New Drug (IND) Application for Phase II Clinical Trial of CardiolRx™ for Acute Myocarditis

August 24, 2021

Press Release

Cardiol Therapeutics to Commence Trading on NASDAQ Under the Symbol “CRDL”

August 09, 2021

Press Release

Cardiol Therapeutics’ Board of Directors Appoints Dr. Guillermo Torre-Amione as Chairman

July 07, 2021

Press Release

Cardiol Therapeutics Reports Results of 2021 Annual General and Special Meeting

June 30, 2021

Page 2 of 10«12345...10...»Last »
  • About Us
  • Therapeutic Areas
  • Research
  • Pipeline
  • CardiolRX™
  • Investors
  • Contact

TSX:CRDL NASDAQ:CRDL

Sign up to receive the latest news from Cardiol Therapeutics

© 2022 Cardiol Therapeutics Inc. All rights reserved.      Terms of Use      Privacy Policy